Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases

Pancreatology

Volumn 2, Issue 1, 2002, Pages 17-25

  Costentin, Lydie ^a   Pagès, Philippe ^a   Bouisson, Michèle ^a   Berthelémy, Philippe ^a   Buscail, Louis ^a   Escourrou, Jean ^a   Pradayrol, Lucien ^a   Vaysse, Nicole ^a  

^a CHU RANGUEIL   (France)

Author keywords

Chronic pancreatitis; DPC4; p16; Pancreatic cancer; Pancreatic juice

Indexed keywords

PROTEIN; PROTEIN P16; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILIARY TRACT DISEASE; CHRONIC PANCREATITIS; CODON; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXON; FEMALE; FOLLOW UP; GENE DELETION; GENE INACTIVATION; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS JUICE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0036286024     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000049443     Document Type: Article

References (37)

1. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
2. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
3. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas
4. K-ras oncogene activation in adenocarcinoma of the human pancreas: A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization
5. Analysis of the Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer
6. K-Ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas
7. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma
8. K-ras mutations and benign pancreatic disease
9. Duct changes and K-ras mutations in the disease-free pancreas: Analysis of type-age relation and spatial distribution
10. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease
11. Advances from genetic clues in pancreatic cancer
12. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
13. A cell cycle regulator potentially involved in genesis of many tumor types
14. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors
15. Abrogation of the Rb/p16 tumor suppressive pathway in virtually all pancreatic carcinomas
16. DPC4 a candidate tumor suppressor gene at human chromosome 18q21.1
17. Tumor-suppressive pathways in pancreatic carcinoma
18. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer
19. Pancreatography in chronic pancreatitis: International definitions
20. Detection of K-ras mutation in stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
21. DPC4 gene in various tumor types
22. Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification
23. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas
24. Coffee, pancreatic cancer and K-ras mutations: Updating the research agenda
25. Identification of K-ras oncogene mutations in pure pancreatic juice of patients with ductal pancreatic cancer
26. Clinical applications of ras gene mutation for diagnosis of pancreatic carcinoma
27. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas
28. Frequent c-Kiras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation
29. Rebuilding the road to cancer
30. Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer
31. Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas
32. Genetic alterations in chronic pancreatitis: Evidence for early occurrence of p53 but not K-ras mutations
33. International Pancreatitis Study Group: Pancreatitis and the risk of pancreatic cancer
34. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer
35. Relation of pancreatic duct hyperplasia to carcinoma
36. Loss of heterozygosity and microsatellite instability in non-neoplastic mucosa from patients with chronic ulcerative colitis
37. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis